A Prospective Evaluation of Carilizumab Combined With Concurrent Chemoradiotherapy in High-risk PD-L1 Positive Stage III-IVA Cervical Cancer One-arm Phase II Clinical Study
Latest Information Update: 19 Dec 2023
At a glance
- Drugs Camrelizumab (Primary) ; Carboplatin; Cisplatin
- Indications Adenocarcinoma; Cervical cancer; Squamous cell cancer
- Focus Therapeutic Use
Most Recent Events
- 22 Jun 2020 New trial record